Last synced on 20 December 2024 at 11:05 pm

Mers-Cov And Common Respiratory Pathogens Multiplex Nucleic Acid Detection System

Page Type
Product Code
Definition
A Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and common respiratory pathogens multiplex nucleic acid detection system is a qualitative in vitro diagnostic test for the detection and identification of MERS-CoV and common respiratory pathogens – associated nucleic acids in human clinical specimens. The test is indicated for individuals meeting specific MERS-CoV clinical and/or epidemiological criteria. It aids in the differential diagnosis of MERS-CoV infection in conjunction with other clinical, epidemiologic, and laboratory data, in accordance with the guidelines provided by the appropriate public health authorities.
Physical State
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and common respiratory pathogens multiplex nucleic acid detection systems are in vitro diagnostic devices that consist of reagents and associated instrumentation for detection and identification of MERS-CoV and common respiratory pathogens – associated nucleic acids in human clinical specimens.
Technical Method
A qualitative in vitro diagnostic assay that detects and identifies MERS-CoV and common respiratory pathogens – associated nucleic acids in human clinical specimens.
Target Area
In vitro diagnostic device
Regulation Medical Specialty
Pathology
Review Panel
Microbiology
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
866.4001
GMP Exempt?
No
Summary Malfunction Reporting
Eligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

Product code PZF is linked to regulation 21CFR866.4001, which does not seem to exist yet. It may be pending at the moment.

Mers-Cov And Common Respiratory Pathogens Multiplex Nucleic Acid Detection System

Page Type
Product Code
Definition
A Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and common respiratory pathogens multiplex nucleic acid detection system is a qualitative in vitro diagnostic test for the detection and identification of MERS-CoV and common respiratory pathogens – associated nucleic acids in human clinical specimens. The test is indicated for individuals meeting specific MERS-CoV clinical and/or epidemiological criteria. It aids in the differential diagnosis of MERS-CoV infection in conjunction with other clinical, epidemiologic, and laboratory data, in accordance with the guidelines provided by the appropriate public health authorities.
Physical State
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and common respiratory pathogens multiplex nucleic acid detection systems are in vitro diagnostic devices that consist of reagents and associated instrumentation for detection and identification of MERS-CoV and common respiratory pathogens – associated nucleic acids in human clinical specimens.
Technical Method
A qualitative in vitro diagnostic assay that detects and identifies MERS-CoV and common respiratory pathogens – associated nucleic acids in human clinical specimens.
Target Area
In vitro diagnostic device
Regulation Medical Specialty
Pathology
Review Panel
Microbiology
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
866.4001
GMP Exempt?
No
Summary Malfunction Reporting
Eligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

Product code PZF is linked to regulation 21CFR866.4001, which does not seem to exist yet. It may be pending at the moment.